Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer

OBJECTIVES: Effective management of adverse events (AEs) following vandetanib treatment is important to maximize clinical benefits. We examined whether more frequent contact with vandetanib-treated patients reduced AEs of CTCAE grade 2 or higher. STUDY DESIGN: In this open-label, multicentre, phase...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur Thyroid J
Hoofdauteurs: Bastholt, Lars, Kreissl, Michael C., Führer, Dagmar, Maia, Ana L., Locati, Laura D., Maciel, Léa, Wu, Yi, Heller, Kevin N., Webster, Alan, Elisei, Rossella
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: S. Karger AG 2016
Onderwerpen:
Clinical Thyroidology / Original Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5091223/
https://ncbi.nlm.nih.gov/pubmed/27843809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448919
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items